Suppr超能文献

胰岛素样生长因子 1 受体和 c-Src 在血管平滑肌细胞中内皮素-1 和血管紧张素 II 诱导的 PKB 磷酸化、肥大和增殖反应中的作用。

Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.

机构信息

Laboratory of Cell Signaling, Montreal Diabetes Research Centre, Centre de Recherche, Centre hospitalier de l'Université de Montréal (CRCHUM), Technopole Angus Campus, and Department of Medicine, University of Montreal, Montréal, Quebec, Canada.

出版信息

Can J Physiol Pharmacol. 2009 Dec;87(12):1009-18. doi: 10.1139/Y09-056.

Abstract

Endothelin-1 (ET-1) and angiotensin II (Ang II) are vasoactive peptides believed to contribute to the pathogenesis of vascular abnormalities such as hypertension, atherosclerosis, hypertrophy, and restenosis. The concept of transactivation of growth factor receptors, such as epidermal growth factor receptor (EGFR), in triggering vasoactive peptide-induced signaling events has gained much recognition during the past several years. We have demonstrated that insulin-like growth factor type 1 receptor (IGF-1R) plays a role in transducing the effect of H2O2, leading to protein kinase B (PKB) phosphorylation. Since vasoactive peptides elicit their responses through generation of reactive oxygen species, including H2O2, we investigated whether IGF-1R transactivation plays a similar role in ET-1- and Ang II-induced PKB phosphorylation and hypertrophic responses in vascular smooth muscle cells (VSMC). AG1024, a specific inhibitor of IGF-1R protein tyrosine kinase (PTK), attenuated both ET-1- and Ang II-induced PKB phosphorylation in a dose-dependent manner. ET-1 and Ang II treatment also induced the phosphorylation of tyrosine residues in the autophosphorylation sites of IGF-1R, which were blocked by AG1024. In addition, both ET-1 and Ang II evoked tyrosine phosphorylation of c-Src, a nonreceptor PTK, whereas pharmacological inhibition of c-Src PTK activity by PP2, a specific inhibitor of Src-family tyrosine kinase, significantly reduced PKB phosphorylation as well as tyrosine phosphorylation of IGF-1R induced by the 2 vasoactive peptides. Furthermore, protein and DNA synthesis enhanced by ET-1 and Ang II were attenuated by AG1024 and PP2. In conclusion, these data suggest that IGF-1R PTK and c-Src PTK play a critical role in mediating PKB phosphorylation as well as hypertrophic and proliferative responses induced by ET-1 and Ang II in A10 VSMC.

摘要

内皮素-1(ET-1)和血管紧张素 II(Ang II)是血管活性肽,被认为有助于高血压、动脉粥样硬化、肥大和再狭窄等血管异常的发病机制。在过去几年中,生长因子受体(如表皮生长因子受体(EGFR))的转激活概念在触发血管活性肽诱导的信号事件中得到了广泛认可。我们已经证明胰岛素样生长因子 1 型受体(IGF-1R)在传递 H2O2 的作用中起作用,导致蛋白激酶 B(PKB)磷酸化。由于血管活性肽通过生成包括 H2O2 在内的活性氧来发挥其作用,我们研究了 IGF-1R 转激活是否在 ET-1 和 Ang II 诱导的血管平滑肌细胞(VSMC)中的 PKB 磷酸化和肥大反应中起类似作用。IGF-1R 蛋白酪氨酸激酶(PTK)的特异性抑制剂 AG1024 以剂量依赖性方式减弱了 ET-1 和 Ang II 诱导的 PKB 磷酸化。ET-1 和 Ang II 处理还诱导 IGF-1R 自身磷酸化位点的酪氨酸残基磷酸化,这被 AG1024 阻断。此外,ET-1 和 Ang II 均引发非受体 PTK c-Src 的酪氨酸磷酸化,而 Src 家族酪氨酸激酶的特异性抑制剂 PP2 抑制 c-Src PTK 活性可显著降低 2 种血管活性肽诱导的 PKB 磷酸化以及 IGF-1R 的酪氨酸磷酸化。此外,ET-1 和 Ang II 增强的蛋白质和 DNA 合成被 AG1024 和 PP2 减弱。总之,这些数据表明,IGF-1R PTK 和 c-Src PTK 在介导 ET-1 和 Ang II 诱导的 A10 VSMC 中的 PKB 磷酸化以及肥大和增殖反应中起关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验